Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satavaptan in the Prevention of Ascites Recurrence (SPARe-1)
NCT00359437Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Jul 2006
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 24
01
Overview
A Phase 3 trial of satavaptan in ascites, sponsored by Sanofi. Started Jul 2006; status: terminated.
02
Drugs
satavaptan
03
Conditions
ascites
Beyond the preview
Go deeper on NCT00359437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359437.